Tag: psilocybin

New Mexico Governor Signs Bill To Create Psilocybin Therapy Program, Legalizing Medical Use Of The Psychedelic

New Mexico’s governor has signed a bill into law to establish a therapeutic psilocybin program in the state.

Weeks after the proposal from Sen. Jeff Steinborn (D) advanced through the legislature, Gov. Michelle Lujan Grisham (D) gave it final approval on Monday.

The Medical Psilocybin Act will allow patients with certain qualifying conditions to access the psychedelic and use it under the guidance of a licensed healthcare provider.

The measure says the purpose “is to allow the beneficial use of psilocybin in a regulated system for alleviating qualified medical conditions,” including major treatment-resistant depression, PTSD, substance use disorders and end-of-life care. The state Department of Health would be able to approve additional conditions.

Under the newly signed legislation, psilocybin therapy will consist of a preparation session, an administration session and a follow-up integration session.

The state health department will be responsible for establishing guidelines around training for clinicians and producers, including dosage, approved settings for administration, production and storage protocols and other best practices. State officials will also license producers to grow mushrooms and process psilocybin.

Keep reading

Iowa Lawmakers Unanimously Approve Bill To Create Psilocybin Program That Would Treat Up To 5,000 Patients With PTSD

An Iowa House committee has unanimously approved a Republican-led proposal to create a state-regulated therapeutic psilocybin program for adults with PTSD.

The bill, HF 620, from Rep. John Wills (R), passed the House Ways and Means Committee on a 23–0 vote at a hearing Thursday.

If enacted into law, it would allow up to 5,000 patients in the state to legally access psilocybin produced in-state by licensed entities. Administration sessions would need to be supervised by registered facilitators—mostly medical professionals—who would need to complete state-specified psilocybin education.

Psilocybin providers would need to be doctors, advanced nurse practitioners, advanced practice nurses, psychologists or social workers who complete psilocybin continuing education requirements, register with the state and pay a registration fee.

Administration sessions themselves would need to be at registered clinical locations and would need to be video recorded. Those records would need to be available for inspection by state officials upon request.

The psilocybin itself would be produced by state-licensed establishments. Local governments could not outright ban those facilities, nor could they deny them appropriate licenses based merely on the fact that psilocybin violates federal law.

Notably, a licensed psilocybin production facility could be co-located with one of the state’s few licensed medical cannabis producers—known in Iowa as medical cannabidiol producers—and the bill says regulators may grant psilocybin licensing preferences to those existing cannabis producers. Facilities couldn’t be located within 1,000 feet of a community location or 500 feet of a residential area.

Only people 21 and older and without “a misdemeanor for drug distribution or any felony” could work at psilocybin producers, and licensees themselves would face background checks.

Up to four independent testing labs could be licensed under the bill, and the state could also establish its own lab.

License applications would be accepted beginning July 1, 2026.

To oversee the system, the legislation would create a state Psilocybin Production Establishment Licensing Board under the Iowa Department of Health and Human Services (HHS).

Appointed by the director of that department, the board would include a member of the public with knowledge of psilocybin, a member with knowledge and experience in the pharmaceutical or nutraceutical manufacturing industry, a law enforcement member, a university chemist or researcher with experience in manufacturing, a member who has a background in fungus or mushroom cultivation and processing.

Keep reading

Nevada Lawmakers Discuss Plan To Create Psychedelic Therapy Pilot Program

A Nevada bill that would create a psychedelic therapy pilot program for military veterans and first responders had its first committee hearing on Wednesday. Lawmakers heard testimony from reform advocates, veterans and their families and members of a state Psychedelic Medicines Working Group, which late last year called on lawmakers to establish a system for regulated access.

The legislation, AB 378, was filed March 10 by Assemblymember Max Carter (D) and 18 other cosponsors. Under the proposal, the state would establish an Alternative Therapy Pilot Program under the Department of Health and Human Services (HHS).

The program would allow the medically supervised use of psychedelics including psilocybin, DMT, ibogaine and mescaline, specifically among military veterans and first responders with certain mental health conditions.

While the Assembly Committee on Health and Human Services didn’t act on the legislation at Wednesday’s hearing, they took testimony and asked questions of some speakers.

Carter, speaking to the panel, said that psychedelic therapy—involving ketamine, which is not part of the current bill—helped him overcome “profound, deep grief, treatment-resistant depression” and complex post-traumatic stress disorder after the traumatic death of his wife.

He explained that the pilot program would focus on first responders and military veterans because “those are demographics that everybody can identify with, but more importantly, they’re ones with accelerated—or exacerbated—suicide rates.”

“When we come back here in two years,” Carter told colleagues, “my belief is this will be mainstream therapy.”

Notably, no members of the public at Wednesday’s hearing spoke in opposition to the proposal, nor did any offer neutral comments.

Keep reading

Florida House And Senate Panels Pass Bills To Criminalize Sales Of Psychedelic Mushroom Spores

Agricultural legislation in Florida containing a provision to outlaw psychedelic mushroom spores has proceeded past two more lawmaking panels in the House and Senate.

The proposed ban on spores of mushrooms that create psilocybin or psilocin is part of roughly 150-page companion bills that would make a variety of adjustments to Florida’s agricultural laws, including around agricultural lands, utilities and wildlife management.

With respect to psychedelic mushrooms, both would outlaw transporting, importing, selling or giving away “spores or mycelium capable of producing mushrooms or other material which will contain a controlled substance, including psilocybin or psilocyn, during its lifecycle.”

Violating the proposed law would be a first-degree misdemeanor, carrying a maximum one year in jail and $1,000 fine.

On Wednesday, the House Criminal Justice Subcommittee passed HB 651, from sponsor Rep. Kaylee Tuck (R), on a 14–4 vote. Prior to the vote, the body adopted an amendment that simplifies the language of the psychedelic spore prohibition but doesn’t meaningfully change it.

Tuck explained to members at the hearing that the change “restructures” the language “to simplify the prohibition without changing the substance of the underlying bill.”

Later in the day, the Senate Appropriations Committee on Agriculture, Environment and General Government favorably reported SB 700, by Sen. Keith Truenow (R).

While senators didn’t discuss the bill’s spore provision at the hearing, one public commenter, identified as Daniel Freeman, opposed it.

Keep reading

Minnesota Lawmakers File Bill To Legalize Psilocybin Possession And Cultivation

Minnesota lawmakers have introduced a bill that would legalize the non-commercial possession and cultivation of psilocybin by adults 21 and older.

Rep. Andy Smith (D) filed the legislation on Monday, with seven original cosponsors. The measure largely informed by the findings and recommendations of a task force that was established under a separate bill that Gov. Tim Walz (D) signed into law in 2024.

“I’ve had a couple folks ask me this: ‘We’re in a tight moment. Inflation is rising. Why is this something that you’re working on?’” Smith, who served on the task force and whose prior legislation created the body, told Marijuana Moment in a phone interview on Tuesday. “And it goes back to, all of us recognize, know someone or struggle ourselves with mental health—and that has been apparent for a while.”

“I think the pandemic highlighted how much we have to go as a society and how we deal with very complex issues, and these medications have shown, in studies, to have great potential to help in that,” Smith said. “I think that’s why it’s important—and it’s important to move on these quickly and responsibly.”

Under the lawmaker’s proposal, the state law would be revised to make it so adults would not face criminal or civil penalties for the personal “use, possession, transportation and cultivation.”

The purpose section of the legislation states that the reform is meant to “reduce the burden on the criminal justice system, promote harm reduction, and enable individuals to make personal decisions regarding the use of psilocybin without fear of prosecution.”

A Psychedelic Medicine Board would be established under the bill to establish possession limits. Smith said that requirement—as well as components that may prove more controversial in an especially divided legislature such as decriminalizing cultivation—will likely be up for debate as the measure moves through the process.

Keep reading

Using Psychedelics Is Tied To 25% Lower Likelihood Of ‘Frequent Bad Headaches,’ Study Shows

People who have used so-called “classic psychedelics” such as psilocybin or LSD are less likely to report having frequent bad headaches, a new study concludes.

The results, authors wrote this month in the Journal of Pharmacology, “add to the literature suggesting classic psychedelics as a possible future prophylactic treatment option for primary headache disorders.”

Researchers gathered data from 11,419 records collected from 1999 to 2000 as part of the British Child Development Study 1958, which follows a cohort of people born over the course of a single week in March 1958.

Specifically, they looked at responses to three questions: “Do you often have bad headaches?” “Have you ever tried LSD, also known as acid or trips?” and “Have you ever tried magic mushrooms?”

The team’s analysis showed that “lifetime use of classic psychedelics was associated with 25% lower odds of having frequent bad headaches.”

There are, of course, limitations as to what conclusions can be drawn from the observational nature of the study.

“Although we have proposed a direction of association, we cannot draw any causal inferences about the association between lifetime use of classic psychedelics and frequent bad headaches,” they wrote. “It is possible that the negative association found is a result of people suffering from frequent bad headaches abstaining from the use of classic psychedelics.”

Data from the same survey, for example, showed that low alcohol use was associated with higher likelihood of frequent bad headaches. In that case, authors interpreted the finding by saying it “may be explained by individuals experiencing frequent bad headaches choosing to abstain from alcohol,” noting that alcohol is understood to be a trigger for headaches.

Overall, 16 percent of people in the survey reported frequent bad headaches. Of those, 71 percent were female and 29 percent were male. Lifetime use of classic psychedelics, meanwhile, was reported by 6.5 percent of people with frequent bad headaches and 8.6 percent of those without.

Notably, when the research team divided reports by sex, they noticed a stronger association between psychedelics use and headaches among female respondents.

Keep reading

Florida Lawmakers Approve Bills To Outlaw Psychedelic Mushroom Spores

Florida House and Senate panel have approved sweeping agriculture legislation that, among other changes, would explicitly outlaw the distribution of psychedelic mushroom spores and mycelium.

Members of the House Housing, Agriculture and Tourism Subcommittee voted at a hearing Tuesday to advance a bill, HB 651, from sponsor Rep. Kaylee Tuck (R). The nearly 150-page measure would make a variety of adjustments to Florida’s agricultural laws, including around agricultural lands, utilities and wildlife management.

With respect to psychedelics mushrooms, it would make it illegal “to transport, import, sell, offer for sale, furnish, or give away spores or mycelium capable of producing mushrooms or other material which will contain a controlled substance, including psilocybin or psilocyn, during its lifecycle.”

Violating the proposed law would be a first-degree misdemeanor, carrying a maximum of one year in jail and a $1,000 fine.

A companion bill, SB 700, which contains the same mushroom provisions, has been introduced in the Senate by Sen. Keith Truenow (R). It was amended and approved unanimously last week by the Senate Appropriations Committee on Agriculture, Environment and General Government.

Prior to reporting the bill favorably on Tuesday, the House panel adopted a striking amendment that made a number of changes to the underlying bill, though the amendment did not substantively affect the provision dealing with spores and mycelium.

Psilocybin and psilocin are the two leading psychoactive compounds in psychedelic mushrooms. Although spores typically do not contain psilocybin or psilocin themselves, they eventually produce fruiting bodies—mushrooms—that do contain the psychedelic compounds.

Because the spores don’t contain any controlled substances, the federal government deems them legal.

“If the mushroom spores (or any other material) do not contain psilocybin or psilocin (or any other controlled substance or listed chemical), the material is considered not controlled,” Terrence Boos, the Drug Enforcement Administration’s (DEA) Drug and Chemical Evaluation Section chief, said in a memo last year. (Using a similar rationale, Boos has said that marijuana seeds are considered federally legal hemp because they themselves don’t contain THC.)

In Florida, a legislative report for HB 651 similarly notes that “spores do not contain any psilocybin properties themselves and therefore could be considered legal under current law.”

To prevent that, the proposal would clarify as illegal any spores or mycelium that could produce psilocybin or psilocin at any time in their development.

Members of the House panel did not mention the broad agriculture legislation’s psilocybin provisions during Tuesday’s hearing.

Keep reading

New Mexico Senate Passes Bill To Create Psilocybin Therapy Program

The New Mexico Senate has passed a bill to establish a therapeutic psilocybin program in the state.

After clearing three separate committees over the past month, the legislation from Sen. Jeff Steinborn (D) was approved by the full chamber in a 33-4 vote on Wednesday, sending it to the House of Representatives.

If enacted, the Medical Psilocybin Act would allow patients with certain qualifying conditions to access the psychedelic and use it under the guidance of a licensed healthcare provider.

“I have come to know and become friends with combat veterans, physicians, providers and even practitioners who serve patients dealing with end-of-life anxiety,” Steinborn said on the floor. “This bill seeks to create a carefully calculated, thoughtful and patient program that would be developed by the Department of Health…to allow patients in a medical setting.”

“This is very different from cannabis. It could only be administered in a medical setting by licensed providers,” he said. “Sometimes it can be as effective as one treatment, and people can have long-term relief from that that they’re dealing with.”

The sponsor added that “we recognize the important need of continuing to do research, so we have the best program here, where the Department of Health is making the best available science decisions on medical setting, dosage, et cetera.”

Sen. Jay Block (R), a veteran himself, said that while he was initially “adamantly opposed” to the proposed reform, he has come to better understand the issue as a “right to try” policy for those with serious mental health conditions. He teared up during the Senate debate, recognizing veterans and others who he’s since learned benefitted from the psychedelic.

An amendment from Sen. Katy Huhigg (D) was adopted on the floor to clarify that the use of federally approved psilocybin would be allowed under the state law, but that such products would not be further regulated by the state.

The amendment would also remove a requirement that the department develop “qualifying conditions” for producers and clinicians, add a health care provider to the advisory board that would be created by the bill and strike language the sponsor described as “redundant.”

The measure says its purpose “is to allow the beneficial use of psilocybin in a regulated system for alleviating qualified medical conditions,” including major treatment-resistant depression, PTSD, substance use disorders and end-of-life care. The state Department of Health would be able to approve additional conditions.

Therapy would consist of a preparation session, an administration session and a follow-up integration session.

The state health department would be responsible for establishing guidelines around training for clinicians and producers, including dosage, approved settings for administration, production and storage protocols and other best practices. State officials would also license producers to grow mushrooms and process psilocybin.

Synthetic psilocybin and synthetic analogs of the substance would not be allowed under the proposal.

Keep reading

Missouri Senators Approve Bill To Legalize Psilocybin Therapy For Veterans And Sex Trafficking Survivors

Missouri senators have advanced a bill to allow military veterans and survivors of sex trafficking who have certain mental health conditions to legally access psilocybin therapy.

The Senate Families, Seniors and Health Committee approved the legislation from Sen. Stephen Webber (D) on Wednesday. A similar House bill focused on the psychedelic moved through a separate panel earlier this month.

In addition to being 21 or older, a military veteran or sex trafficking survivor and enrolled in a clinical trial, participants in the proposed program would need to have PTSD, major depressive disorder, a substance use disorder or be in end-of-life care.

They would also need to provide documentation to the state Department of Mental Health about the treating physician, facilitator and location and time of use.

Further, use of psilocybin would be limited to 150 mg during a 12-month period.

The bill also authorizes the state Department of Health to provide up to $3 million worth of grants to support research on the therapeutic potential of psilocybin.

Keep reading

New Hampshire Lawmakers Unanimously Approve Psilocybin Decriminalization Bill

A House committee in New Hampshire has advanced a bill that would decriminalize use and possession of psilocybin.

Members of the House Criminal Justice and Public Safety voted unanimously, 16–0, to pass the bill, HB 528, from Rep. Kevin Verville (R).

Prior to moving the bill forward, the committee first adopted an amendment to temper the proposed reform. As originally introduced, it would have completely removed all penalties around obtaining, purchasing, transporting, possessing or using psilocybin, effectively legalizing it on a noncommercial basis.

The amended version of the legislation imposes penalties, but they’re significantly lower than the state’s current felony-level prohibition.

Under the new amendment, a first psilocybin offense would be a violation, subject to a fine of $100 or less. Second and third offenses would be class B misdemeanors, carrying fines of up to $500 and $1,000, respectively, but also with no risk of jail time.

Fourth and subsequent offenses would still be classified as felonies.

Notably, language of the proposal does not include any specific limit to the amount of psilocybin a person could possess.

The committee’s chair, Rep. Terry Roy (R), said that while he opposes full legalization of psilocybin, he believes the drug has medical value and ought not be punished as a felony.

“I’d like to see it done through proper scientific channels, through university studies and the [Department of Veterans Affairs],” Roy explained. “But having said that, I support this bill lowering it from a felony. We don’t need more intoxicated people, but we also don’t need more felons.”

Keep reading